发明名称 COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT
摘要 A method of treating a subject in need of a non-syngeneic cell or tissue graft is disclosed. The method comprising: (a) transplanting into a subject a dose of T cell depleted immature hematopoietic cells, wherein the T cell depleted immature hematopoietic cells comprise less than 5×105 CD3+ T cells per kilogram body weight of the subject, and wherein the dose comprises at least about 5×106 CD34+ cells per kilogram body weight of the subject; and subsequently (b) administering to the subject a therapeutically effective amount of cyclophosphamide, wherein the therapeutically effective amount comprises 25-200 mg per kilogram body weight, thereby treating the subject.
申请公布号 US2014363437(A1) 申请公布日期 2014.12.11
申请号 US201214367917 申请日期 2012.12.20
申请人 Yeda Research and Development Co. Ltd. 发明人 Reisner Yair;Bachar-Lustig Esther
分类号 A61K35/28;A61K31/7076;A61K31/661;A61K39/395 主分类号 A61K35/28
代理机构 代理人
主权项 1. A method of treating a subject in need of a non-syngeneic cell or tissue graft, the method comprising: (a) transplanting into a subject a dose of T cell depleted immature hematopoietic cells, wherein said T cell depleted immature hematopoietic cells comprise less than 5×105 CD3+ T cells per kilogram body weight of the subject, and wherein said dose comprises at least about 5×106 CD34+ cells per kilogram body weight of the subject; and subsequently (b) administering to the subject a therapeutically effective amount of cyclophosphamide, wherein said therapeutically effective amount comprises 25-200 mg per kilogram body weight, thereby treating the subject.
地址 Rehovot IL